You are in the Policy Library of OMB Watch's Regulatory Resource Center.
⇒ Return to Policy Library home.
⇒ Switch to the Advocacy Center.
Signed by President Clinton in September 1993, Executive Order 12,866 replaces President Reagan's E.O. 12,291 and 12,498, outlining the regulatory principles and polices that have remained the cornerstone of White House administrative policy ever since. E.O. 12,866 establishes the guiding principles agencies must follow when developing regulations, including encouraging the use of cost-benefit analysis, risk assessment, and performance-based regulatory standards. The executive order also establishes the regulatory planning process for each agency, delegating authority to the Office of Information and Regulatory Affairs (OIRA) to coordinate agency rulemaking efforts with the regulatory priorities of the President. E.O. 12,866 also expands the roles of OIRA in rulemaking through a centralized review of regulations, whereby OIRA acts as gatekeeper for the promulgation of all significant rulemakings.
While making some improvements to the transparency and accountability of White House involvement in agency rulemaking, Clinton's E.O. 12,866 continued to advocate the use of Reagan-era anti-regulatory tools such as cost-benefit analysis, risk assessment and cost-effectiveness to calculate public protections. Under the leadership of President George W. Bush's appointee John Graham, the Office of Information and Regulatory Affairs has even further expanded on the provisions of E.O. 12,866 through various guidance documents and bulletins. OIRA's expanded role in agency rulemaking has also frequently led to weaker public protections that often serve the private sector far better than the general public. Read more about OIRA's meddling in agency rulemaking.
E.O. 12,866 has three main components:
E.O. 12,866 requires that federal agencies promulgate regulation only in so far as the regulations are:
In deciding if regulation is necessary, agencies must assess the costs and benefits of the regulation as well as the regulatory alternatives, "including the alternative of not regulating." "[U]nless statute requires another regulatory approach," agencies must also choose the regulatory alternative that maximizes net benefits. The regulatory principles of E.O. 12,866 do not apply to regulations from independent agencies, such as the Consumer Product Safety Commission.
Other regulations that are exempt from these requirements include rules pertaining to a military or foreign affairs function or other regulations exempted by the administrator of OIRA.
For applicable agencies and regulations, the executive order mandates that agencies follow a host of guiding principles when developing regulatory priorities, including the following:
Section 4 of 12,866 outlines the regulatory planning process. The regulatory planning process includes three major steps:
The executive order also establishes a regulatory working group headed by the OIRA administrator for the identification and analysis of rulemaking issues, such as "the development of innovative regulatory techniques" or "the methods, efficacy, and utility of comparative risk assessment in regulatory decision-making." The OIRA administrator is also given authority to consult with outside groups on regulatory initiatives or existent regulations of concern to them.
E.O. 12,866 expands the role of the Office of Information and Regulatory Affairs in the rulemaking process through the centralized review process. Though OIRA is given the authority ostensibly "to ensure that regulations are consistent with applicable law, the President's priorities, and the principles set forth in this Executive order, and that decisions made by one agency do not conflict with the policies or actions taken or planned by another agency," the role of OIRA in rulemaking is often far more pervasive and substantive than the executive order circumscribes.
E.O. 12,866 grants OIRA the authority to review periodically existing significant regulations from federal agencies as well as to review new significant regulations under consideration by an agency. Significant regulatory action is defined as any regulatory action that "will likely result in a rule that may:
OIRA, not the agency, makes the final determination of which rules are considered to be significant. For all significant rulemakings, the agencies must provide OIRA with the text of regulation, a statement of need, and "an assessment of costs and benefits of the regulatory action."
Economically significant regulations must meet additional analytical requirements: Anticipated benefits and costs must be quantified to the extent possible; Agencies must provide cost-benefit analysis of reasonable alternatives and "an explanation of why the planned regulatory action is preferable to the identified potential alternatives."
OIRA has 90 days to complete the review, with the possibility of one 30 day extension. Agencies cannot publish the rule in the Federal Register until OIRA's review has been completed the review without a request for further consideration by the agency or the 90 days has expired without a response from OIRA. If OIRA does return the rule to the agency or requests changes of any kind, the agency must reconsider the rulemaking, addressing OIRA's concerns.
In an improvement over its predecessors, E.O. 12,866 does include some efforts to increase transparency and public participation in the rulemaking process. The executive order directs the agencies to "provide the public with meaningful participation in the regulatory process." The executive order also attempts to shed some light on OIRA's involvement in agency rulemaking, including requiring the following:
Unfortunately, as both GAO and OMB Watch investigations have discovered, these provisions for transparency are frequently ignored by agencies and OIRA. OIRA's documentation of outside communications is also largely inadequate. Though a log of meetings is available online, the log is only sporadically updated and often the rule in discussion is not properly identified.